ENVARSUS PA
KNIGHT THERAPEUTICS INC.
Quick answers
Is there a shortage of ENVARSUS PA in Canada?
No. There is no current shortage of ENVARSUS PA 1MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
SANDOZ TACROLIMUS
SANDOZ CANADA INCORPORATED
ADVAGRAF
ASTELLAS PHARMA CANADA INC
ACH-TACROLIMUS
ACCORD HEALTHCARE INC
SANDOZ TACROLIMUS XR
Extended-ReleaseSANDOZ CANADA INCORPORATED
ENVARSUS PA
KNIGHT THERAPEUTICS INC.
PROGRAF
ASTELLAS PHARMA CANADA INC
DIN
02485885
Strength
1MG
Dosage Form
Tablet (Extended-Release)
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from KNIGHT THERAPEUTICS INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02468735
0.5MG · DIN 02381729
0.25MG · DIN 02381710
DIN 02332450
1G · DIN 02242980
DIN 02505223
400MG · DIN 02245828
30MG · DIN 02296152
DIN 02290308
25MG · DIN 01997602
20MG · DIN 01997572
5MG · DIN 01924516